APPLICATION
ANDA202279
TYPE
ANDA
ORIGINAL APPROVAL
2014-11-20
LATEST ACTION
2023-05-23
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
ZOLMITRIPTANPrescription
ZOLMITRIPTAN 5MG · TABLET · ORAL
ZOLMITRIPTANPrescription
ZOLMITRIPTAN 2.5MG · TABLET · ORAL
Approval history
2023-05-23Labeling · Supplement 5 · standardAP
2014-11-20OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.